Glow LifeTech Corp. is a promising Canadian-based biotechnology startup established in 2018. It operates in the Biotechnology and Life Sciences sectors, specializing in the development of nutraceutical and cannabinoid-based products. The company’s primary innovation is its proprietary MyCell™ Technology, a plant-based, pharma-grade delivery system that enhances the bioavailability, absorption, and effectiveness of natural compounds.
This technology transforms poorly absorbed substances into water-compatible concentrates, unlocking the full healing potential of natural active compounds. Glow LifeTech not only creates its own in-house brands such as MOD™️ and .decimal™️—focusing primarily on cannabis—but also collaborates with top-tier health-focused brands to produce high-performance natural health products. These products, powered by MyCell™ Technology, offer enhanced effectiveness and precise dosing without synthetic additives or unpleasant tastes.
The company has not yet disclosed its latest funding round or investors, indicating potential investment opportunities for stakeholders seeking innovation in the natural health domain.